Where Tech Meets Bio
Latest News
Basetwo, an AI platform for manufacturing engineers, has raised $11.5 million in Series A funding. The funding will support the development of Basetwo’s Physics AI …
Read More
Insilico Medicine Doses First Patient With AI-Designed Pan-TEAD Inhibitor
Insilico Medicine, a clinical-stage biotechnology company leveraging generative AI for drug discovery, has dosed the first patient in its global Phase I trial of ISM6331, …
Read More
Advarra Launches Study Collaboration Solution to Accelerate Clinical Trial Startup
Advarra, a provider of regulatory review solutions and clinical research technology, has introduced its Study Collaboration solution, designed to streamline site activation workflows, improve stakeholder …
Read More
Latest News
RyboDyn Uncovers Dark Proteome, Secures $4M Pre-Seed for Cancer Immunotherapy
Icelandic Biotech Raises €26.5M for Clinical-Stage Dementia and Skin Disease Treatments
Tempus Announces National Launch of AI-Powered Personal Health Assistant
Study: Trust in Scientists Post-Pandemic Remains High, but Public Wants More Engagement
Mayo Clinic Partners with Microsoft and Cerebras on Radiology and Genomics Foundation Models
Longevity Company Rubedo Announces Phase 1 Trials for GPX4 Modulator Targeting Aging Cells and Surrounding Tissues
Latest Insights
by Nikhil Pradhan
Legal and Governance Considerations in AI for Drug Discovery: New Paradigms and 2025 Outlook
Just in time for 2025 prediction season, a survey of the emerging AI drug discovery landscape, prepared by Chris Bradbury, has been making the rounds—and …
Read More
by Andrii Buvailo, PhD
Microbiome, Aging, and the Synthetic Immune System: A New Frontier in Geroscience
What does aging have in common with pathogens like bacteria and viruses? And how does the quest to tackle antimicrobial drug resistance -- an alarmingly …
Read More
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
by Megan Deegan
21 Life Science Marketplaces to Try in 2024
by Andrii Buvailo
FTI Survey: Healthcare & Life Sciences Optimism, M&A and AI to Drive 2025 Growth
by BiopharmaTrend
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
by Thomas Fessard
Legal and Governance Considerations in AI for Drug Discovery: New Paradigms and 2025 Outlook
by Nikhil Pradhan
The AI-driven Development Journey of ISM5411, a Potential Breakthrough Treatment for Inflammatory Bowel Disease
by Andrii Buvailo, PhD
The Importance of Accurate Patient Matching for AI Projects
by Huzaifa Ali
Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads
by Roman Kasianov
From Our Partners
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Sponsored by
Lantern Pharma
AI Breaches the Barrier Towards Better CNS Drug Discovery
Sponsored by
SpiroChem
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Partner Events
Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››
London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
BIOCHINA 2025
Event Date: March 13, 2025 - March 15, 2025
Location: China (Suzhou International Expo Center)
Website: Link
Promo Code: biopharmatrend (valid till 2024-10-31)
Read more ›››
The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link
Case Studies
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Interviews
Alex Zhavoronkov: Linking Chemistry and Biology Using Artificial Intelligence
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Turbocharging Phenotypic Screening with AI to Target mRNA Biology
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Most Read
The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between
Six AI-driven Drug Discovery Companies Enabling Precision Oncology
The Time for Breakthroughs in Antibiotic Discovery
Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography